Anmelden

Vertragslandschaft — OmniVision

156.836
Vertraege
101.538.101.107.939 EUR
Gesamtvolumen
20.027
Auftragnehmer
1 Vertraege gefunden (Seite 1 von 1)
Liste Nach Auftraggeber Nach Gewinner
▶ GWQ ServicePlus AG
2 Vertraege
▶ Unbekannt
2 Vertraege
Acetylcystein (OTC) | Acetylcystein (LSE) | Amantadin | Atenolol + Chlortalidon | Baclofen (INF) | Beclometason (DOS) | Beclometason (NAS, NDS, SUV) | Betamethason (CRE) | Betamethason (EMU) | Betamethason (LOE) | Betamethason (SAL) | Bezafibrat (FTA, RET) | Budesonid (DOS) | Budesonid (IHP) | Buprenorphin (PFT; 3 Tage) | Buprenorphin (0,2 mg, 0,4 mg; SUT) | Cabergolin | Calcipotriol + Betamethason (SAL) | Calcipotriol + Betamethason (GEL) | Captopril + Hydrochlorothiazid | Chinin | Ciclopirox (VCR, VSU) | Clobazam (SUE) | Clobazam (TAB) | Clotrimazol Kombipackung | Codein (TAB) | Dexamethason (ATR) | Entacapon | Epinephrin (PEN) | Fentanyl (LUT) | Fesoterodin | Formoterol (6 µg; IHP) | Granisetron (FTA) | Granisetron (IFK) | Ketorolac | Maraviroc (FTA, LSE) | Metamizol (ILO) | Methocarbamol (FTA, IIL) | Moclobemid | Mometason furoat (CRE) | Mometason furoat (LOE) | Mometason furoat (SAL) | Naltrexon | Nifedipin (RET) | Sulpirid (HKP, TAB) | Tacrolimus (Prograf, Advagraf) | Terazosin | Testosteron (180 mg; ILO) | Tiaprid | Tizanidin | Tolperison | Triacylglycerollipase (40.000 PhEur.-E.)
Rahmenvertrag (21 Bieter) 20.01.2026 · 52 Lose ted_europa
k.A.
Acarbose | Atenolol | Baclofen (TAB) | Bimatoprost (0,1 mg; 0,12 mg) | Bosutinib | Brinzolamid + Brimonidin | Budesonid (SUV) | Buprenorphin (PFT; 7 Tage) | Cetirizin (LSE, SAF, LOE, TRO) | Ciclopirox (CRE, LOE) | Cyproteron + Ethinylestradiol | Ebastin (FTA) | Eisencarboxymaltose (IID) | Fluoxetin (20 mg) | Formoterol (12 µg; HPI) | Formoterol (12 µg; IHP) | Formoterol (12,5 µg: HPI) | Ginkgoblätter Trockenextrakt (FTA) | Hydromorphon (AMP, IIL, ILO) | Isotretinoin | Lactulose (SIR) | Lansoprazol | Loperamid (RX) | Loperamid (OTC) | Loratadin | Memantin (LSE) | Methocarbamol (750 mg) | Methocarbamol (1500 mg) | Methylphenidat (RET; 30 St) | Nilotinib | Propranolol (10 mg) | Ramipril + Amlodipin | Risedronsäure | Sulfasalazin | Tacrolimus (SAL) | Triacylglycerollipase (20.000 PhEur.-E.) | Triacylglycerollipase (25.000 PhEur.-E.) | Triamcinolon acetonid (CRE) | Acetylsalicylsäure (100 mg; OTC) | Aprepitant (HKP) | Atomoxetin (HKP) | Bimatoprost (0,3 mg) | Bosentan | Brimonidin (ATR, EDP) | Buprenorphin (PFT; 4 Tage) | Buprenorphin (0,4 mg, 2 mg, 8 mg; SUT) | Cetirizin (FTA) | Dasatinib | Dimethylfumarat | Emtricitabin + Tenofovir disoproxil | Enalapril + Lercanidipin | Entecavir | Etoricoxib | Exemestan | Febuxostat | Flecainid | Hydromorphon (REK, RET) | Hydromorphon (HKP) | Irbesartan + Hydrochlorothiazid | Letrozol | Levetiracetam (FTA) | Levetiracetam (IFK) | Levocetirizin (OTC) | Mometason furoat (NAS, NDS) | Olanzapin (FTA, SMT, TAB, UTA) | Pirfenidon (FTA) | Pomalidomid | Rasagilin | Rivaroxaban | Solifenacin | Tenofovir disoproxil | Testosteron (1000 mg; ILO) | Travoprost | Valsartan | Valsartan + Hydrochlorothiazid
Rahmenvertrag (33 Bieter) 20.01.2026 · 75 Lose ted_europa
k.A.